Joseph S. Zakrzewski, Director at Cyteir Therapeutics, Inc. (CYT), bought 3,700 shares at $11.12 ($40K) on 2021-12-15, disclosed to the SEC on 2021-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.47 | 2,000 | $21K | 52.6% |
| 2 | $11.12 | 1,700 | $19K | 47.4% |
| Total | $10.77 avg | 3,700 | $40K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |